| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.83B | 52.10B | 54.33B | 54.60B | 52.80B | 53.75B |
| Gross Profit | 10.12B | 10.61B | 10.15B | 9.92B | 8.69B | 9.05B |
| EBITDA | 508.50M | 485.00M | 1.05B | 732.00M | 658.00M | 1.35B |
| Net Income | 93.00M | 329.00M | 420.00M | 84.00M | 120.00M | 613.00M |
Balance Sheet | ||||||
| Total Assets | 36.23B | 35.99B | 35.73B | 39.70B | 37.89B | 36.35B |
| Cash, Cash Equivalents and Short-Term Investments | 4.81B | 4.52B | 5.22B | 8.01B | 7.78B | 6.84B |
| Total Debt | 1.32B | 1.19B | 1.36B | 5.09B | 4.10B | 2.62B |
| Total Liabilities | 9.86B | 8.49B | 9.31B | 13.01B | 11.54B | 9.98B |
| Stockholders Equity | 26.36B | 27.49B | 26.41B | 26.69B | 26.34B | 26.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -108.00M | 1.08B | -1.19B | -600.00M | -1.20B |
| Operating Cash Flow | 0.00 | -32.00M | 1.13B | -71.00M | 647.00M | -1.02B |
| Investing Cash Flow | 0.00 | -203.00M | 55.00M | -345.00M | -968.00M | 0.00 |
| Financing Cash Flow | 0.00 | -460.00M | -3.99B | 638.00M | 1.24B | 139.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥17.79B | 10.87 | ― | 3.42% | 43.76% | 124.74% | |
66 Neutral | ¥165.08B | 9.48 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥8.12B | 25.37 | ― | 3.25% | -4.10% | -25.38% | |
62 Neutral | ¥71.43B | 8.76 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥63.44B | 12.92 | ― | 2.73% | -1.96% | 26.37% | |
54 Neutral | ¥2.73B | -1.75 | ― | 4.68% | 1.19% | -2435.84% |